semaglutide weight loss willowbrook Chicago Willow for Weight Loss -

doi: 10.1542/peds.2020-1610

Status of Other GLP-1 Products: As of February 21, 2025, the FDA is also monitoring other GLP-1 medications: Dulaglutide injection : Still in shortage, though the manufacturer has reported all presentations are available

Reference: Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial by Sean Wharton, Paula Freitas, Jran Hjelmesth, Maria Kabisch, Kristian Kandler, Ildiko Lingvay, Maria Quiroga, Julio Rosenstock and W Timothy Garvey, 14 September 2025, The Lancet Diabetes & Endocrinology

The manufacturer funding may not have influenced the study results

Step 4: Use the washout period to stabilize your eating patterns

K., Pedersen, J